Medical Cannabis for Migraines in the UK

Migraine is one of the most disabling neurological conditions in the UK. For patients with chronic migraine — or frequent episodic migraine that has not responded to standard preventive and acute treatments — a specialist may consider cannabis-based medicines as an additional option in the management plan.

What is Migraine?

Migraine is a complex neurological disorder characterised by recurrent attacks of moderate to severe headache, typically unilateral and pulsating in quality, often accompanied by nausea, vomiting, and extreme sensitivity to light and sound. Aura — visual disturbances, sensory changes, or speech difficulties — occurs in approximately one third of migraine sufferers before or during the headache phase. Migraine attacks can last from 4 to 72 hours and can render the individual unable to function at work or in daily life.

The distinction between episodic and chronic migraine is clinically significant. Episodic migraine involves fewer than 15 headache days per month; chronic migraine is defined as 15 or more headache days per month for more than three months, of which at least eight fulfil migraine criteria. Chronic migraine is associated with higher rates of disability, depression, anxiety, and sleep disruption than episodic migraine, and it is significantly more difficult to treat. Medication overuse headache — a complicating factor in which frequent use of acute headache treatments leads to a chronic daily headache pattern — is an important consideration in patients who use acute treatments more than 10 to 15 days per month.

Standard acute treatments include triptans (sumatriptan, rizatriptan, zolmitriptan) and in some cases gepants (rimegepant) or lasmiditan. Preventive treatments — intended to reduce migraine frequency and severity — include propranolol, topiramate, amitriptyline, candesartan, and for chronic migraine with inadequate response, botulinum toxin A (Botox) injections and CGRP monoclonal antibodies (erenumab, fremanezumab, galcanezumab) under specialist care. Despite this extensive toolkit, a proportion of chronic migraine patients continue to experience an unacceptably high headache burden.

Medical Cannabis and Migraine — What Does the Evidence Say?

The evidence base for cannabis-based medicines in migraine is growing, though it remains less extensive than for chronic pain or neuropathic conditions. The endocannabinoid system is known to be involved in central pain processing and the trigeminovascular system — the pathway implicated in migraine pathophysiology — providing a clear biological rationale for cannabinoid intervention.

Observational studies from medical cannabis programmes report that migraine patients frequently cite headache frequency and severity reduction as primary outcomes. A retrospective study in the United States reported that medical cannabis use was associated with a significant reduction in migraine attacks per month. A small Italian randomised controlled trial found that a cannabinoid combination reduced acute migraine pain at two hours and showed preventive effects comparable to amitriptyline over three months, though with different side effect profiles.

The evidence most strongly supports the use of cannabis-based medicines in the preventive management of chronic migraine rather than as a first-line acute treatment for individual attacks. UK specialists considering prescribing for migraine will focus on whether conventional preventive strategies have been adequately tried and have failed, and whether the patient's headache burden justifies the risks and costs of cannabis-based treatment.

Who Qualifies for a Medical Cannabis Prescription for Migraine?

• Confirmed diagnosis: A documented diagnosis of chronic migraine or frequent episodic migraine, ideally by a neurologist or headache specialist.
• Significant headache burden: Chronic migraine (15+ headache days per month) or episodic migraine causing substantial functional impairment despite preventive treatment.
• Failed conventional preventives: At least two appropriate preventive agents tried without adequate reduction in migraine frequency — for example, propranolol and topiramate, or Botox if eligible.
• Absence of medication overuse: Patients using acute treatments on more than 10 to 15 days per month may need a supervised medication overuse management plan before being considered appropriate candidates for cannabis prescribing.
• UK residency and adult age.

What to Expect from a Medical Cannabis Consultation for Migraine

A consultation for migraine will involve a detailed headache history: the frequency, duration, and severity of attacks, associated symptoms (aura, nausea, photophobia), triggers identified, all acute and preventive treatments tried, and current medication use. The prescribing specialist will assess for medication overuse headache, which must be addressed before or alongside any new treatment. Cannabis-based medicines for migraine are most commonly considered as a preventive therapy — taken regularly rather than only at the onset of an attack. Products used include CBD-dominant or balanced formulations, with THC-containing preparations used where pain severity and sleep disruption are significant features. Daily oil dosing is the most commonly employed approach.

How Much Does Medical Cannabis Cost for Migraine in the UK?

• Initial consultation: £79 to £200.
• Monthly medication: £100 to £350 per month depending on product and dose.
• Follow-up appointments: £50 to £100 per session, typically every one to three months.

Frequently Asked Questions — Medical Cannabis for Migraines UK

Can cannabis be used as an acute treatment during a migraine attack?

Some patients use vaporised cannabis acutely at the onset of an attack, and some report benefit. However, the evidence for acute migraine treatment is less well established than for preventive use, and the risk of contributing to medication overuse headache with frequent acute dosing is a clinical concern.

Will medical cannabis interact with my triptans?

Clinically significant interactions between cannabis-based medicines and triptans are not well documented, but your prescribing specialist must review your full medication list before prescribing. Never alter your existing acute migraine medications without medical guidance.

I have been prescribed Botox for chronic migraine. Can I also use cannabis?

Botulinum toxin A injections and cannabis-based medicines are not mutually exclusive, and some patients use them concurrently under specialist supervision. Your neurologist and cannabis prescriber should be aware of each other's involvement in your care.

Does medical cannabis help cluster headaches?

Cluster headache is a distinct primary headache disorder from migraine. Some patients with cluster headache report benefit from cannabis-based medicines, but the evidence base is even more limited than for migraine. Specialist assessment is required and cluster headache patients should be under care of a headache specialist.

Can I drive when using medical cannabis for migraine prevention?

THC-containing products impair driving ability. UK law sets blood-concentration limits and police use roadside DrugWipe testing. This is an important practical consideration for regular preventive dosing. Discuss driving fully with your prescribing specialist before starting treatment.